Transaction in Own Shares

GlaxoSmithKline PLC 19 February 2008 GlaxoSmithKline plc (the 'Company') announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 23 May 2007 it purchased 2,158,000 of its Ordinary shares of 25 pence each ('shares') on 19 February 2008 at a price of 1142.3555 pence per share. The shares will be cancelled. Following the cancellation of these shares, the Company holds 504,194,158 of its shares in Treasury, representing 9.18% of the total voting rights in the Company. The Company has 5,489,997,767 shares in issue (excluding Treasury shares). This number represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Services Authority's Disclosure and Transparency Rules. This announcement does not constitute, or form part of, an offer or any solicitation of an offer to purchase or subscribe for securities in any jurisdiction and is in conformity with the Financial Services Authority's Disclosure and Transparency Rules. This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings